{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:18:47Z","timestamp":1771067927563,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12325-024-02988-6","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T08:49:24Z","timestamp":1733388564000},"page":"772-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-4894","authenticated-orcid":false,"given":"Naoto","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runa","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Odanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-7440","authenticated-orcid":false,"given":"Hiroshi","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kisara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitae","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2988_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003550","volume":"18","author":"KE Lafond","year":"2021","unstructured":"Lafond KE, Porter RM, Whaley MJ, et al. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: a systematic review and meta-analysis. PLoS Med. 2021;18: e1003550. https:\/\/doi.org\/10.1371\/journal.pmed.1003550.","journal-title":"PLoS Med"},{"key":"2988_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10995-019-02844-y","volume":"24","author":"THT Quach","year":"2020","unstructured":"Quach THT, Mallis NA, Cordero JF. Influenza vaccine efficacy and effectiveness in pregnant women: systematic review and meta-analysis. Matern Child Health J. 2020;24:229\u201340. https:\/\/doi.org\/10.1007\/s10995-019-02844-y.","journal-title":"Matern Child Health J"},{"key":"2988_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101751","volume":"36","author":"M Liang","year":"2020","unstructured":"Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;36: 101751. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101751.","journal-title":"Travel Med Infect Dis"},{"key":"2988_CR4","doi-asserted-by":"publisher","first-page":"e4329","DOI":"10.1093\/cid\/ciaa1517","volume":"73","author":"R Hirose","year":"2021","unstructured":"Hirose R, Ikegaya H, Naito Y, et al. Survival of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and influenza virus on human skin: importance of hand hygiene in coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73:e4329\u201335. https:\/\/doi.org\/10.1093\/cid\/ciaa1517.","journal-title":"Clin Infect Dis"},{"key":"2988_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4415\/ann_18_01_10","volume":"54","author":"LS D\u2019Angiolella","year":"2018","unstructured":"D\u2019Angiolella LS, Lafranconi A, Cortesi PA, et al. Costs and effectiveness of influenza vaccination: a systematic review. Ann Ist Super Sanita. 2018;54:49\u201357. https:\/\/doi.org\/10.4415\/ann_18_01_10.","journal-title":"Ann Ist Super Sanita"},{"key":"2988_CR6","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1016\/j.vaccine.2021.09.054","volume":"39","author":"Y Sugishita","year":"2021","unstructured":"Sugishita Y, Sugawara T. Effectiveness and cost-effectiveness of influenza vaccination for elderly people. Vaccine. 2021;39:7531\u201340. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.054.","journal-title":"Vaccine"},{"key":"2988_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jval.2022.03.011","volume":"25","author":"D Loong","year":"2022","unstructured":"Loong D, Pham B, Amiri M, et al. Systematic review on the cost-effectiveness of seasonal influenza vaccines in older adults. Value Health. 2022;25:1439\u201358. https:\/\/doi.org\/10.1016\/j.jval.2022.03.011.","journal-title":"Value Health"},{"key":"2988_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/irv.12814","volume":"15","author":"K Taniguchi","year":"2021","unstructured":"Taniguchi K, Ikeda S, Hagiwara Y, et al. Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: a systematic literature review and vaccine effectiveness meta-analysis. Influenza Other Respir Viruses. 2021;15:293\u2013314. https:\/\/doi.org\/10.1111\/irv.12814.","journal-title":"Influenza Other Respir Viruses"},{"key":"2988_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/21645515.2017.1405200","volume":"14","author":"JY Heo","year":"2018","unstructured":"Heo JY, Song JY, Noh JY, et al. Effects of influenza immunization on pneumonia in the elderly. Hum Vaccin Immunother. 2018;14:744\u20139. https:\/\/doi.org\/10.1080\/21645515.2017.1405200.","journal-title":"Hum Vaccin Immunother"},{"key":"2988_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.vhri.2020.07.579","volume":"24","author":"N Nakagawa","year":"2021","unstructured":"Nakagawa N, Morikawa A, Kanazawa Y, et al. A cost-effectiveness analysis of neuraminidase inhibitors for influenza virus infections in an adult-outpatient setting in Japan. Value Health Reg Issues. 2021;24:117\u201322. https:\/\/doi.org\/10.1016\/j.vhri.2020.07.579.","journal-title":"Value Health Reg Issues"},{"key":"2988_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/00019053-200624040-00007","volume":"24","author":"B Sander","year":"2006","unstructured":"Sander B, Hayden FG, Gyldmark M, et al. Post-exposure influenza prophylaxis with oseltamivir: cost-effectiveness and cost utility in families in the UK. Pharmacoeconomics. 2006;24:373\u201386. https:\/\/doi.org\/10.2165\/00019053-200624040-00007.","journal-title":"Pharmacoeconomics"},{"key":"2988_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta13110","volume":"13","author":"P Tappenden","year":"2009","unstructured":"Tappenden P, Jackson R, Cooper K, et al. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technol Assess. 2009;13:1\u2013246. https:\/\/doi.org\/10.3310\/hta13110.","journal-title":"Health Technol Assess"},{"key":"2988_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105499","volume":"210","author":"JC Jones","year":"2023","unstructured":"Jones JC, Yen HL, Adams P, et al. Influenza antivirals and their role in pandemic preparedness. Antiviral Res. 2023;210: 105499. https:\/\/doi.org\/10.1016\/j.antiviral.2022.105499.","journal-title":"Antiviral Res"},{"key":"2988_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14715\/cmb\/2023.69.13.3","volume":"69","author":"LM Dom\u00ednguez","year":"2023","unstructured":"Dom\u00ednguez LM, Matla KM, Leyva JR, et al. Antiviral resistance in influenza viruses. Cell Mol Biol (Noisy-le-grand). 2023;69:16\u201323. https:\/\/doi.org\/10.14715\/cmb\/2023.69.13.3.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2988_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJMoa1915341","volume":"383","author":"H Ikematsu","year":"2020","unstructured":"Ikematsu H, Hayden FG, Kawaguchi K, et al. Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med. 2020;383:309\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1915341.","journal-title":"N Engl J Med"},{"key":"2988_CR16","doi-asserted-by":"publisher","first-page":"1900170","DOI":"10.2807\/1560-7917.es.2019.24.12.1900170","volume":"24","author":"E Takashita","year":"2019","unstructured":"Takashita E, Kawakami C, Ogawa R, et al. Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalized child without prior baloxavir treatment. Jpn Euro Surveill. 2019;24:1900170. https:\/\/doi.org\/10.2807\/1560-7917.es.2019.24.12.1900170.","journal-title":"Jpn Euro Surveill"},{"key":"2988_CR17","unstructured":"Wolters Kluwer. UpToDate: seasonal influenza in adults: role of antiviral prophylaxis for prevention. https:\/\/www.uptodate.com."},{"key":"2988_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jama.285.6.748","volume":"285","author":"R Welliver","year":"2001","unstructured":"Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285:748\u201354. https:\/\/doi.org\/10.1001\/jama.285.6.748.","journal-title":"JAMA"},{"key":"2988_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1056\/nejm200011023431801","volume":"343","author":"FG Hayden","year":"2000","unstructured":"Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of influenza in families: Zanamivir family study group. N Engl J Med. 2000;343:1282\u20139. https:\/\/doi.org\/10.1056\/nejm200011023431801.","journal-title":"N Engl J Med"},{"key":"2988_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cid\/ciw255","volume":"63","author":"S Kashiwagi","year":"2016","unstructured":"Kashiwagi S, Watanabe A, Ikematsu H, et al. Long-acting neuraminidase inhibitor laninamivir octanoate as post-exposure prophylaxis for influenza. Clin Infect Dis. 2016;63:330\u20137. https:\/\/doi.org\/10.1093\/cid\/ciw255.","journal-title":"Clin Infect Dis"},{"key":"2988_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379:913\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1716197.","journal-title":"N Engl J Med"},{"key":"2988_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000362","volume":"7","author":"X Duval","year":"2010","unstructured":"Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010;7: e1000362. https:\/\/doi.org\/10.1371\/journal.pmed.1000362.","journal-title":"PLoS Med"},{"key":"2988_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/656802","volume":"51","author":"A Watanabe","year":"2010","unstructured":"Watanabe A, Chang SC, Kim MJ, et al. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis. 2010;51:1167\u201375. https:\/\/doi.org\/10.1086\/656802.","journal-title":"Clin Infect Dis"},{"key":"2988_CR24","unstructured":"Ministry of Health, Labour and Welfare, Japan. Medical Fee Index (Shinryo-hoshu, 2020 Version). https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000188411_00027.html."},{"key":"2988_CR25","unstructured":"Organisation for Economic Co-Operation and Development. Purchasing Power Parities (PPP), OECD Data. https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm."},{"key":"2988_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hec.1481","volume":"19","author":"T Shiroiwa","year":"2010","unstructured":"Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost-effectiveness? Health Econ. 2010;19:422\u201337. https:\/\/doi.org\/10.1002\/hec.1481.","journal-title":"Health Econ"},{"key":"2988_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3851\/imp3189","volume":"23","author":"M Higashiguchi","year":"2018","unstructured":"Higashiguchi M, Matsumoto T, Fujii T. A meta-analysis of laninamivir octanoate for treatment and prophylaxis of influenza. Antivir Ther. 2018;23:157\u201365. https:\/\/doi.org\/10.3851\/imp3189.","journal-title":"Antivir Ther"},{"key":"2988_CR28","doi-asserted-by":"publisher","first-page":"Doc02","DOI":"10.3205\/id000071","volume":"9","author":"SC Duwe","year":"2021","unstructured":"Duwe SC, Schmidt B, G\u00e4rtner BC, et al. Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations. GMS Infect Dis. 2021;9:Doc02. https:\/\/doi.org\/10.3205\/id000071.","journal-title":"GMS Infect Dis."},{"key":"2988_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2991\/jegh.k.200402.001","volume":"10","author":"M Dronavalli","year":"2020","unstructured":"Dronavalli M, Lord H, Alexander K, et al. Effectiveness of oseltamivir prophylaxis in influenza outbreaks in residential aged care. J Epidemiol Glob Health. 2020;10:184\u20139. https:\/\/doi.org\/10.2991\/jegh.k.200402.001.","journal-title":"J Epidemiol Glob Health"},{"key":"2988_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/npm-15814124","volume":"8","author":"LM Ghulmiyyah","year":"2015","unstructured":"Ghulmiyyah LM, Alame MM, Mirza FG, et al. Influenza and its treatment during pregnancy: a review. J Neonatal Perinatal Med. 2015;8:297\u2013306. https:\/\/doi.org\/10.3233\/npm-15814124.","journal-title":"J Neonatal Perinatal Med"},{"key":"2988_CR31","first-page":"49","volume":"59","author":"V Kute","year":"2011","unstructured":"Kute V, Goplani KR, Godara SM, et al. Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient\u2013safe and effective without any immunosuppresive drug interaction. J Assoc Physicians India. 2011;59:49\u201351.","journal-title":"J Assoc Physicians India"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-02988-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:54:32Z","timestamp":1738407272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-02988-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-02988-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors, Naoto Nakagawa, Runa Ono, Keita Odanaka, Hiroshi Ohara, Shigeki Kisara, and Kitae Ito, declare no potential conflicts of interest concerning the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the ethics commission of the university where the authors hold faculty positions (no. 330). The authors submitted a letter describing the study\u2019s purpose under the condition that identifiable information would never be made public. The students were also advised that they would experience no disadvantage for refusing to participate in the study at any time. Written letters of intent were obtained from the participants. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}